Logo image of PHGE

BIOMX INC (PHGE) Stock Overview

NYSEARCA:PHGE - US09090D3017 - Common Stock

0.56 USD
+0.01 (+1.82%)
Last: 8/26/2025, 12:19:29 PM

PHGE Key Statistics, Chart & Performance

Key Statistics
52 Week High1.23
52 Week Low0.34
Market Cap14.86M
Shares26.53M
Float20.33M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.73
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12/bmo
IPO12-18 2018-12-18
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PHGE short term performance overview.The bars show the price performance of PHGE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

PHGE long term performance overview.The bars show the price performance of PHGE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PHGE is 0.56 USD. In the past month the price increased by 27.04%. In the past year, price decreased by -54.91%.

BIOMX INC / PHGE Daily stock chart

PHGE Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.65 367.55B
AMGN AMGEN INC 13.26 155.69B
GILD GILEAD SCIENCES INC 14.81 142.24B
VRTX VERTEX PHARMACEUTICALS INC 22.73 98.72B
REGN REGENERON PHARMACEUTICALS 12.79 61.85B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.02B
ARGX ARGENX SE - ADR 75.52 42.84B
ONC BEONE MEDICINES LTD-ADR 6.22 36.59B
INSM INSMED INC N/A 27.74B
BNTX BIONTECH SE-ADR N/A 25.11B
NTRA NATERA INC N/A 22.59B
BIIB BIOGEN INC 8.53 20.02B

About PHGE

Company Profile

PHGE logo image BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. The firm is focused on developing both natural and engineered phage therapies. The company develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The firm discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Company Info

BIOMX INC

22 Einstein St., Floor 4

Ness Ziona MARYLAND 7414002 IL

CEO: Jonathan Solomon

Employees: 55

PHGE Company Website

PHGE Investor Relations

Phone: 972723942377

BIOMX INC / PHGE FAQ

What is the stock price of BIOMX INC today?

The current stock price of PHGE is 0.56 USD. The price increased by 1.82% in the last trading session.


What is the ticker symbol for BIOMX INC stock?

The exchange symbol of BIOMX INC is PHGE and it is listed on the NYSE Arca exchange.


On which exchange is PHGE stock listed?

PHGE stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for BIOMX INC stock?

8 analysts have analysed PHGE and the average price target is 18.87 USD. This implies a price increase of 3269.64% is expected in the next year compared to the current price of 0.56. Check the BIOMX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOMX INC worth?

BIOMX INC (PHGE) has a market capitalization of 14.86M USD. This makes PHGE a Nano Cap stock.


How many employees does BIOMX INC have?

BIOMX INC (PHGE) currently has 55 employees.


What are the support and resistance levels for BIOMX INC (PHGE) stock?

BIOMX INC (PHGE) has a support level at 0.39 and a resistance level at 0.56. Check the full technical report for a detailed analysis of PHGE support and resistance levels.


Should I buy BIOMX INC (PHGE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOMX INC (PHGE) stock pay dividends?

PHGE does not pay a dividend.


When does BIOMX INC (PHGE) report earnings?

BIOMX INC (PHGE) will report earnings on 2025-11-12, before the market open.


What is the Price/Earnings (PE) ratio of BIOMX INC (PHGE)?

BIOMX INC (PHGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).


What is the Short Interest ratio of BIOMX INC (PHGE) stock?

The outstanding short interest for BIOMX INC (PHGE) is 1.61% of its float. Check the ownership tab for more information on the PHGE short interest.


PHGE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to PHGE. When comparing the yearly performance of all stocks, PHGE is a bad performer in the overall market: 90.35% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PHGE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PHGE. The financial health of PHGE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PHGE Financial Highlights

Over the last trailing twelve months PHGE reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS decreased by -60.04% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.8%
ROE -96.91%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%72.86%
Sales Q2Q%N/A
EPS 1Y (TTM)-60.04%
Revenue 1Y (TTM)N/A

PHGE Forecast & Estimates

8 analysts have analysed PHGE and the average price target is 18.87 USD. This implies a price increase of 3269.64% is expected in the next year compared to the current price of 0.56.


Analysts
Analysts82.5
Price Target18.87 (3269.64%)
EPS Next Y25.64%
Revenue Next YearN/A

PHGE Ownership

Ownership
Inst Owners43.18%
Ins Owners1.48%
Short Float %1.61%
Short Ratio0.05